Meihekou Central Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Liver cirrhosis1 trial
• Psoriasis1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Beijing Protgen Biotechnology Development Co., Ltd.1 trial
• Beijing Tiantan Hospital1 trial
• InSilico Medicine Hong Kong Limited1 trial
• Janssen Research & Development, LLC1 trial
• Newsoara Biopharma Co., Ltd.1 trial

Running trials

• Recruiting

  Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)

  NCT07265570· Phase 2· InSilico Medicine Hong Kong Limited· Source

  Contact: Yang Deng

• Active, not recruiting

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis1 recruiting

Closed trials

• Completed

  HPP737 in Adult Patients With Plaque Psoriasis

  NCT07712731· Phase 3· Newsoara Biopharma Co., Ltd.· Source

• Completed

  Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

  NCT06553456· Phase 2/3· Beijing Protgen Biotechnology Development Co., Ltd.· Source

• Completed

  ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)

  NCT05507645· Phase 3· Beijing Tiantan Hospital· Source